Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07475546 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination Gerotherapeutic Interventions for Healthspan Improvement

Name: Combination Gerotherapeutic Interventions for Healthspan Improvement — clinical trial record (NCT07475546)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 3

SponsorAgelessRx

Started2025-07-23

View on ClinicalTrials.gov ↗

Record status

This record was last updated March 16, 2026 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.

AgelessRx

3 trials monitored

See all monitored trials

This study is a 90-day interventional, randomized, controlled pilot trial exploring multi-modal gerotherapies and their impact on longevity-related outcomes. In this proof-of-concept phase, a small sample size of up to 30 subjects (10 subjects in each arm) will be randomized into one of the three arms: 1) Control, 2) Multi-therapy (B12, Naltrexone, Metformin, and NAD+), or 4) Comprehensive Therapy (Rapamycin, Naltrexone, Metformin, B12, NAD+, GSH, and Infinite Supplement).

Trial Details

NCT Number	NCT07475546
Lead Sponsor	AgelessRx
Conditions	Healthspan Improvement, Aging, Longevity
Enrollment	30 participants
Start Date	2025-07-23
Primary Completion	2026-04 (estimated)
Study Completion	2026-04 (estimated)
Updated on ClinicalTrials.gov	2026-03-16